bioAffinity Technologies (BIAF) Interest & Investment Income (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Interest & Investment Income of $10026.0 for Q1 2026, up 1749.82% year-over-year from $542.0 in Q1 2025, and down 49.18% quarter-over-quarter from $19730.0 in Q4 2025.
bioAffinity Technologies (BIAF) Interest & Investment Income (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Interest & Investment Income for 6 consecutive years, with $10026.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income rose 1749.82% year-over-year to $10026.0; the TTM figure through Mar 2026 stood at $32869.0 (up 173.34% YoY), while the FY2025 annual figure was $23385.0, up 32.79% from the prior year.
- Interest & Investment Income declined to $10026.0 in Q1 2026 per BIAF's latest filing, from $19730.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $44124.0 in Q2 2023 and bottomed at $276.0 in Q2 2022.
- Historically, Interest & Investment Income has averaged $13705.6 across 5 years, with a median of $6770.5 in 2022.
- Annual changes were most pronounced in 2022 — Interest & Investment Income soared 38921.05% — and 2024, when it slumped 91.81%.
- bioAffinity Technologies' Interest & Investment Income stood at $38447.0 in 2022, then tumbled by 68.37% to $12160.0 in 2023, then plunged by 66.54% to $4069.0 in 2024, then jumped by 384.89% to $19730.0 in 2025, then slumped by 49.18% to $10026.0 in 2026.
- Business Quant data shows BIAF's Interest & Investment Income at $10026.0 in Q1 2026, $19730.0 in Q4 2025, and $1088.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 207.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 61.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 13.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 7.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 606,000.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 8.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 5.60 Mn |
| 10 | bioAffinity Technologies | 1.78 Mn | -649,139.45 | - | 3,358.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,358.00 |
| Mar 31, 2026 | 10,026.00 |
| Dec 31, 2025 | 19,730.00 |
| Sep 30, 2025 | 1,088.00 |
| Jun 30, 2025 | 2,025.00 |
| Mar 31, 2025 | 542.00 |
| Dec 31, 2024 | 4,069.00 |
| Sep 30, 2024 | 2,228.00 |
| Jun 30, 2024 | 5,186.00 |
| Mar 31, 2024 | 6,127.00 |
| Dec 31, 2023 | 12,160.00 |
| Sep 30, 2023 | 27,193.00 |
| Jun 30, 2023 | 44,124.00 |
| Mar 31, 2023 | 38,654.00 |
| Dec 31, 2022 | 38,447.00 |
| Sep 30, 2022 | 7,414.00 |
| Jun 30, 2022 | 276.00 |
| Dec 31, 2021 | 400.00 |
| Sep 30, 2021 | 19.00 |